RecruitingNot ApplicableNCT07827196

Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial

Transcranial Random Noise (tRNS) for Behavioral and Psychological Symptoms in Alzheimer's Disease (BPSD): A Randomized, Double-blind, Sham-Controlled Trial

Sponsor

Anhui Medical University

Enrollment

40 participants

Start Date

Sep 1, 2026

Study Type

INTERVENTIONAL

Conditions

Alzheimer Disease Electroencephalography BPSD (Behavioral and Psychological Symptoms of Dementia)Transcranial Random Noise Stimulation (tRNS)

Summary

To investigate the treatment effect of Transcranial random noise (tRNS) on Alzheimer patients, and the underlying neural mechanism by EEG.

Eligibility

Min Age: 45 YearsMax Age: 84 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called High frequency transcranial random noise and a medical device called Sham high frequency transcranial random noise for people with alzheimer disease, bpsd (behavioral and psychological symptoms of dementia), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 45 Years to 84 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHigh frequency transcranial random noise

High frequency tRNS is described as a non-invasive form of brain stimulation that uses a low-intensity, alternating current applied directly to the head through scalp electrodes.

DEVICESham high frequency transcranial random noise

In the sham condition, tRNS was delivered only during the ramp-up and ramp-down periods (30s); no current was delivered during the 30-minute intervention.